Peter Attia· MD
Ultimately the utility of subtyping lies in the extent to which doing so can improve clinical outcomes.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Ultimately the utility of subtyping lies in the extent to which doing so can improve clinical outcomes.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it sounds like they're real overarching challenge here is triangulating between neurobiology anatomy functional signaling and then of course ultimately clinical outcomes matter more than any of these other things in the end I agree and that's what should direct all of these in the first place and it's not what's happening now